YCBDNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends September 30
cbdMD, Inc.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.35−0.01 (-2.22%)
Close on Oct 19, 2026
- Market cap
- $3.70M
- P/E (TTM)
- –
- Dividend yield
- –
cbdMD statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Perfumes, Cosmetics & Other Toilet Preparations companies for comparison
Valuation
| Measure | cbdMD | Industry median |
|---|---|---|
| Market Cap | $3.90M | $164.85M |
| Enterprise Value | $1.78M | $87.06M |
| PS Ratio | 0.19 | 3.60 |
| PB Ratio | 0.47 | 2.03 |
| P/TBV Ratio | 0.65 | 2.31 |
Enterprise value
| Measure | cbdMD | Industry median |
|---|---|---|
| EV / Sales | 0.09 | 2.43 |
Income (trailing twelve months)
| Measure | cbdMD | Industry median |
|---|---|---|
| Revenue | $20.93M | $57.94M |
| Gross Profit | $12.07M | $90.47M |
| Operating Income | -$2.90M | -$21.44M |
| Pretax Income | -$2.89M | -$14.45M |
| Net Income | -$2.89M | -$22.46M |
| EBITDA | -$2.90M | -$16.91M |
Margins
| Measure | cbdMD | Industry median |
|---|---|---|
| Gross Margin | 57.7% | 52.3% |
| Operating Margin | -13.9% | -44.5% |
| Pretax Margin | -13.8% | -13.0% |
| Profit Margin | -13.8% | -39.2% |
| EBITDA Margin | -13.9% | -31.3% |
| FCF Margin | -11.5% | -8.85% |
Returns
| Measure | cbdMD | Industry median |
|---|---|---|
| Return on Equity (ROE) | -40.3% | -53.1% |
| Return on Assets (ROA) | -25.1% | -41.0% |
| Return on Invested Capital (ROIC) | -41.2% | -32.0% |
| Return on Capital Employed (ROCE) | -28.8% | -37.8% |
Growth
| Measure | cbdMD | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 10.0% | 6.01% |
| Revenue Growth (3Y CAGR) | -18.5% | 2.25% |
| Revenue Growth (5Y CAGR) | -14.5% | 6.42% |
Balance sheet
| Measure | cbdMD | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $2.12M | $62.42M |
| Net Cash (Debt) | $2.12M | $15.68M |
| Net Cash Per Share | $0.19 | $0.66 |
| Equity (Book Value) | $8.21M | $48.79M |
| Book Value Per Share | $0.73 | $1.36 |
| Tangible Book Value | $6.04M | $23.06M |
| Working Capital | $4.62M | $75.77M |
Financial position
| Measure | cbdMD | Industry median |
|---|---|---|
| Current Ratio | 2.50 | 3.30 |
| Quick Ratio | 0.99 | 2.39 |
Cash flow (trailing twelve months)
| Measure | cbdMD | Industry median |
|---|---|---|
| Operating Cash Flow | -$2.22M | -$12.35M |
| Capital Expenditures | -$191.42K | -$1.06M |
| Free Cash Flow | -$2.41M | -$20.28M |
| FCF Per Share | -$0.22 | -$0.42 |
Efficiency
| Measure | cbdMD | Industry median |
|---|---|---|
| Asset Turnover | 1.82 | 0.38 |
| Inventory Turnover | 2.67 | 2.67 |
| Revenue Per Employee | $498.37K | $398.96K |
| Profits Per Employee | -$68.77K | -$703.34K |
| Employee Count | 42 | 74 |
Dividends and yields
| Measure | cbdMD | Industry median |
|---|---|---|
| Earnings Yield | -74.0% | -22.7% |
| FCF Yield | -61.8% | -9.07% |
Shares
| Measure | cbdMD | Industry median |
|---|---|---|
| Shares Outstanding | 11,205,000 | 58,179,650 |
| Shares Change (QoQ) | 5.94% | 0.54% |
| Float | 7,324,100 | 49,173,100 |
| Shares Held by Insiders | 34.6% | 11.6% |
| Shares Held by Institutions | 8.19% | 59.4% |
Scores
| Measure | cbdMD | Industry median |
|---|---|---|
| Altman Z-Score | -17.61 | -0.24 |
| Piotroski F-Score | 6 | 4 |
Calculated by StockData from cbdMD's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.